[Genome-wide association of IL-28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C in a Tunisian population]
Sondes, Bizid; Riadh, Bouali; Amani, Ouedrani; Ali, Mrabet; Hatem, Ben Abdallah; Ezzeddine, Ghazouani; Nabil, Abdelli.
Tunisie Medicale [La]. 2016; 94 (1): 6-11
en Francés
| IMEMR | ID: emr-181771
Background:
A polymorphism upstream of interleukin [IL]-28B was recently identified to be associated with a 2-fold difference in sustained virologic response [SVR] to pegylated interferon-alpha and ribavirin therapy in a large cohort of treatment-naive, adherent patients with chronic hepatitis C [CHC] virus genotype 1 [HCV-1] infection
Biblioteca responsable:
EMRO
Documentos relacionados